chr7-159030677-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_003382.5(VIPR2):āc.1256T>Cā(p.Leu419Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,567,954 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003382.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VIPR2 | NM_003382.5 | c.1256T>C | p.Leu419Pro | missense_variant | 13/13 | ENST00000262178.7 | NP_003373.2 | |
VIPR2 | NM_001308259.1 | c.1208T>C | p.Leu403Pro | missense_variant | 10/10 | NP_001295188.1 | ||
VIPR2 | NM_001304522.2 | c.1016T>C | p.Leu339Pro | missense_variant | 11/11 | NP_001291451.1 | ||
VIPR2 | NR_130758.2 | n.1686T>C | non_coding_transcript_exon_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VIPR2 | ENST00000262178.7 | c.1256T>C | p.Leu419Pro | missense_variant | 13/13 | 1 | NM_003382.5 | ENSP00000262178 | P2 | |
VIPR2 | ENST00000402066.5 | c.1679T>C | p.Leu560Pro | missense_variant | 13/13 | 5 | ENSP00000384497 | A2 | ||
VIPR2 | ENST00000377633.7 | c.1208T>C | p.Leu403Pro | missense_variant | 10/10 | 2 | ENSP00000366860 |
Frequencies
GnomAD3 genomes AF: 0.000703 AC: 107AN: 152232Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000165 AC: 29AN: 175734Hom.: 0 AF XY: 0.000148 AC XY: 14AN XY: 94752
GnomAD4 exome AF: 0.000136 AC: 193AN: 1415604Hom.: 0 Cov.: 31 AF XY: 0.000139 AC XY: 97AN XY: 700262
GnomAD4 genome AF: 0.000715 AC: 109AN: 152350Hom.: 1 Cov.: 33 AF XY: 0.000631 AC XY: 47AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.1256T>C (p.L419P) alteration is located in exon 13 (coding exon 13) of the VIPR2 gene. This alteration results from a T to C substitution at nucleotide position 1256, causing the leucine (L) at amino acid position 419 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at